Recently, the Government Accountability Office (GAO) released a letter that it sent to Sen. Orrin Hatch of Utah regarding Section 1332 Waivers, also known as State Innovation Waivers. These waivers, authorized under the Affordable Care Act (ACA), permit the federal Departments of Health and Human Services (HHS) and Treasury to waive certain aspects of the ACA upon a state’s request. The GAO was asked for information on the status of the waiver review and approval process, and talked to many stakeholders (federal and state officials and advocates) in preparing its response.
Since the passage of the Affordable Care Act (ACA), thirty-one states plus the District of Columbia have expanded Medicaid, providing a substantial base of evidence for the impact of Medicaid expansion, from a variety of perspectives. Data available from these states and a growing research base provide key information about the benefits and the strategic value of expansion.
Recently released CMS guidance and newly established State Plan Amendment authority allows states to use Supplemental Nutrition Assistance Program (SNAP) data, under certain conditions, to enroll and re-determine Medicaid eligibility. In order to assist states in the facilitation of Medicaid enrollment and renewal for eligible SNAP participants, a recent webinar presented some of the necessary considerations for leveraging these data for enrollment purposes.
With the United States in the midst of a worsening opioid epidemic, an examination of the resources and tools available to states in combating this crisis is critical. With Medicaid serving as the largest source of coverage for behavioral health services, including those related to substance use disorders (SUDs), the role that it can occupy in addressing the epidemic is clear. An additional 1.2 million individuals with SUDs have gained access to coverage in states that have expanded Medicaid under the ACA. This issue brief, developed by Manatt Health, reviews Medicaid strategies to combat the opioid epidemic.